Diatide
AcquiredLondonderry, United States · Founded 1990 · $18.7M raised
- Headquarters
- Londonderry, New Hampshire
- Employees
- 11–50
- Founded
- 1990
- Business Model
- B2B
- Total Funding
- $18.7M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Diatide, Inc. (formerly Diatech Inc, NASDAQ: NITI) was a radiopharmaceutical company based in Londonderry, New Hampshire, specializing in peptide engineering, molecular biology, and radiolabeling chemistry. The company developed peptide-based compounds that bind to platelet GPIIb/IIIa receptors labeled with technetium-99m for imaging blood clots. Its key product AcuTect received FDA clearance in September 1998 for scintigraphic imaging of acute venous thrombosis in the lower extremities. Diatide was acquired by Schering Berlin, Inc. (a business unit of Schering AG, Germany) in October 1999.
Summary
Diatide is a Biotech company based in Londonderry, United States, founded in 1990. It has raised $18.7M in total across 1 round. Investors include New Enterprise Associates, Alta Partners and Panorama Capital.
Funding History
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/diatide"><img src="https://indexed.vc/api/badge/company/diatide" alt="Diatide on Indexed.vc" width="260" height="76" /></a>